Kazia Therapeutics (NASDAQ: KZIA) Stock Skyrockets on Promising Brain Cancer Study Results
Kazia Therapeutics stock (NASDAQ: KZIA) skyrocketed during intraday trading on Wednesday following the announcement of phase II/III clinical trial results […]
KZIA
